<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39335711</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>The Impact of the COVID-19 Pandemic on Melanoma Diagnosis: A Single-Center Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2032</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics14182032</ELocationID><Abstract><AbstractText>(1) Background: Melanoma represents the most aggressive form of skin cancer, with an increasing incidence and numerous risk factors. The COVID-19 pandemic has led to modifications in work protocols. This study aims to elucidate potential changes in the number and characteristics of primary melanomas diagnosed in the Pathology Department of the Târgu Mureș County Clinical Hospital before, during, and after the COVID-19 pandemic. (2) Methods: This study included 140 patients grouped into six periods: two pre-COVID-19 periods, the COVID-19 pandemic period, and three post-COVID-19 periods. Epidemiological data, diagnoses, and histopathological reports were analyzed. (3) Results: The number of cases diagnosed during the COVID-19 pandemic was significantly lower than in the other analyzed periods. Regarding the monitored parameters, a statistically significant increase was observed in the first two post-COVID-19 periods, with a return to values similar to those of the first period in the last analyzed period. Additionally, a statistically significant increase in the incidence of distant metastases was identified in the post-COVID-19 periods. (4) Conclusions: The COVID-19 pandemic had a negative impact on the diagnosis of new melanoma cases, leading to an increase in the number of cases and a worsening of prognostic parameters.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sabău</LastName><ForeName>Adrian-Horațiu</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Doctoral School of Medicine and Pharmacy, University of Medicine, Pharmacy, Sciences and Technology "George Emil Palade" of Targu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology "George Emil Palade" of Targu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cocuz</LastName><ForeName>Iuliu-Gabriel</ForeName><Initials>IG</Initials><Identifier Source="ORCID">0000-0001-5985-2433</Identifier><AffiliationInfo><Affiliation>Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology "George Emil Palade" of Targu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niculescu</LastName><ForeName>Raluca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology "George Emil Palade" of Targu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tinca</LastName><ForeName>Andreea Cătălina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology "George Emil Palade" of Targu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szoke</LastName><ForeName>Andreea Raluca</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology "George Emil Palade" of Targu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazar</LastName><ForeName>Bianca-Andreea</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiorean</LastName><ForeName>Diana Maria</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology "George Emil Palade" of Targu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotoi</LastName><ForeName>Ovidiu Simion</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology "George Emil Palade" of Targu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">histopathology</Keyword><Keyword MajorTopicYN="N">melanoma</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39335711</ArticleId><ArticleId IdType="pmc">PMC11431054</ArticleId><ArticleId IdType="doi">10.3390/diagnostics14182032</ArticleId><ArticleId IdType="pii">diagnostics14182032</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Elmas F., Demirbaş A., Düzayak S., Atasoy M., Türsen Ü., Lotti T. Melanoma and COVID-19: A narrative review focused on treatment. Dermatol. Ther. 2020;33:e14101. doi: 10.1111/dth.14101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dth.14101</ArticleId><ArticleId IdType="pubmed">32734626</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzwierzynski W.W. Melanoma Risk Factors and Prevention. Clin. Plast. Surg. 2021;48:543–550. doi: 10.1016/j.cps.2021.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cps.2021.05.001</ArticleId><ArticleId IdType="pubmed">34503715</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanning J.E., Kalsi S., Krag D.N. Impact of the COVID-19 pandemic on melanoma diagnosis and presentation: A review. Int. J. Dermatol. 2023;62:850–856. doi: 10.1111/ijd.16684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.16684</ArticleId><ArticleId IdType="pubmed">37073701</ArticleId></ArticleIdList></Reference><Reference><Citation>Cariti C., Merli M., Avallone G., Rubatto M., Marra E., Fava P., Caliendo V., Picciotto F., Gualdi G., Stanganelli I., et al. Melanoma Management during the COVID-19 Pandemic Emergency: A Literature Review and Single-Center Experience. Cancers. 2021;13:6071. doi: 10.3390/cancers13236071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13236071</ArticleId><ArticleId IdType="pmc">PMC8656565</ArticleId><ArticleId IdType="pubmed">34885180</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocuz I.G., Popelea M.C., Niculescu R., Manea A., Sabău A.-H., Tinca A.-C., Szoke A.R., Budin C.E., Stoian A., Morariu S.H., et al. Pathophysiology, Histopathology, and Differential Diagnostics of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma—An Update from the Pathologist’s Point of View. Int. J. Mol. Sci. 2024;25:2220. doi: 10.3390/ijms25042220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25042220</ArticleId><ArticleId IdType="pmc">PMC10888641</ArticleId><ArticleId IdType="pubmed">38396897</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel R.L., Giaquinto A.N., Jemal A. Cancer statistics, 2024. CA A Cancer J. Clin. 2024;74:12–49. doi: 10.3322/caac.21820.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21820</ArticleId><ArticleId IdType="pubmed">38230766</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurla L.A., Forsea A.-M. Melanoma epidemiology in Europe: What is new? Ital. J. Dermatol. Venereol. 2024;159:128–134. doi: 10.23736/S2784-8671.24.07811-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S2784-8671.24.07811-3</ArticleId><ArticleId IdType="pubmed">38650494</ArticleId></ArticleIdList></Reference><Reference><Citation>Edge S.B. AJCC Cancer Staging Manual. 8th ed. Springer; Berlin/Heidelberg, Germany: 2017. American Joint Committee on Cancer.</Citation></Reference><Reference><Citation>Garbe C., Amaral T., Peris K., Hauschild A., Arenberger P., Basset-Seguin N., Bastholt L., Bataille V., del Marmol V., Dréno B., et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur. J. Cancer. 2022;170:236–255. doi: 10.1016/j.ejca.2022.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2022.03.008</ArticleId><ArticleId IdType="pubmed">35570085</ArticleId></ArticleIdList></Reference><Reference><Citation>Habas K., Nganwuchu C., Shahzad F., Gopalan R., Haque M., Rahman S., Majumder A.A., Nasim T. Resolution of coronavirus disease 2019 (COVID-19) Expert Rev. Anti-Infect. Ther. 2020;18:1201–1211. doi: 10.1080/14787210.2020.1797487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2020.1797487</ArticleId><ArticleId IdType="pubmed">32749914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochani R., Asad A., Yasmin F., Shaikh S., Khalid H., Batra S., Sohail M.R., Mahmood S.F., Ochani R., Hussham Arshad M., et al. COVID-19 pandemic: From origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez. Med. 2021;29:20–36.</Citation><ArticleIdList><ArticleId IdType="pubmed">33664170</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboueshia M., Hussein M.H., Attia A.S., Swinford A., Miller P., Omar M., Toraih E.A., Saba N., Safah H., Duchesne J., et al. Cancer and COVID-19: Analysis of Patient Outcomes. Futur. Oncol. 2021;17:3499–3510. doi: 10.2217/fon-2021-0121.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fon-2021-0121</ArticleId><ArticleId IdType="pmc">PMC8284249</ArticleId><ArticleId IdType="pubmed">34263660</ArticleId></ArticleIdList></Reference><Reference><Citation>Chams N., Chams S., Badran R., Shams A., Araji A., Raad M., Mukhopadhyay S., Stroberg E., Duval E.J., Barton L.M., et al. COVID-19: A Multidisciplinary Review. Front. Public Health. 2020;8:383. doi: 10.3389/fpubh.2020.00383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00383</ArticleId><ArticleId IdType="pmc">PMC7403483</ArticleId><ArticleId IdType="pubmed">32850602</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocuz I.-G., Cocuz M.-E., Niculescu R., Șincu M.C., Tinca A.C., Sabău A.-H., Chiorean D.M., Morariu S.H., Cotoi O.S. The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers—A Single-Center Study in Romania. Medicina. 2021;57:533. doi: 10.3390/medicina57060533.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57060533</ArticleId><ArticleId IdType="pmc">PMC8226979</ArticleId><ArticleId IdType="pubmed">34071770</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanty A., Agnihotri S., Mehta A., Rawal S. COVID-19 and cancer: Sailing through the tides. Pathol.-Res. Pract. 2021;221:153417. doi: 10.1016/j.prp.2021.153417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2021.153417</ArticleId><ArticleId IdType="pmc">PMC7997300</ArticleId><ArticleId IdType="pubmed">33857716</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobhani N., Mondani G., Roviello G., Catalano M., Sirico M., D’angelo A., Scaggiante B., Generali D. Cancer management during the COVID-19 world pandemic. Cancer Immunol. Immunother. CII. 2023;72:3427–3444. doi: 10.1007/s00262-023-03524-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00262-023-03524-1</ArticleId><ArticleId IdType="pmc">PMC10992624</ArticleId><ArticleId IdType="pubmed">37642709</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A.R., Valdebran M., Reuben D.Y. Emerging Developments in Management of Melanoma during the COVID-19 Era. Front. Med. 2021;8:769368. doi: 10.3389/fmed.2021.769368.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.769368</ArticleId><ArticleId IdType="pmc">PMC8606631</ArticleId><ArticleId IdType="pubmed">34820401</ArticleId></ArticleIdList></Reference><Reference><Citation>Not O.J., Breeschoten J., Eertwegh A.J.M., Hilarius D.L., De Meza M.M., Haanen J.B., Blank C.U., Aarts M.J.B., Berkmortel F.W.P.J., Groot J.W.B., et al. The unfavorable effects of COVID-19 on Dutch advanced melanoma care. Int. J. Cancer. 2022;150:816–824. doi: 10.1002/ijc.33833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.33833</ArticleId><ArticleId IdType="pmc">PMC8652896</ArticleId><ArticleId IdType="pubmed">34605003</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry W., Tan K., Haydon A., Shackleton M., Mar V.J. Reduced melanoma referrals during COVID-19 lockdown. Aust. J. Gen. Prac. 2021;50 doi: 10.31128/AJGP-COVID-45.</Citation><ArticleIdList><ArticleId IdType="doi">10.31128/AJGP-COVID-45</ArticleId><ArticleId IdType="pubmed">33543153</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti S., Frosolini A., Catarzi L., Marsiglio A., Gennaro P., Gabriele G. Impact of the COVID-19 Pandemic on the Diagnosis and Management of Non-Melanoma Skin Cancer in the Head and Neck Region: A Retrospective Cohort Study. Healthcare. 2024;12:501. doi: 10.3390/healthcare12040501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare12040501</ArticleId><ArticleId IdType="pmc">PMC10888473</ArticleId><ArticleId IdType="pubmed">38391876</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman R.C., Faur C.I., Gordan E., Văleanu M., Moldovan M.A. Impact of the COVID-19 Pandemic on the Surgical Management of Head and Neck Non-Melanoma Skin Cancers in a Maxillofacial Center of Cluj-Napoca. J. Clin. Med. 2024;13:3934. doi: 10.3390/jcm13133934.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13133934</ArticleId><ArticleId IdType="pmc">PMC11242733</ArticleId><ArticleId IdType="pubmed">38999499</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharf C., Mongardini F.M., Fisone F., Briatico G., Brancaccio G., Chirico F., Tolone S., Docimo L., Gambardella C., Lucido F., et al. Impact of the COVID pandemic on melanoma thickness and ulceration: A meta-analysis. Int. J. Dermatol. 2024 doi: 10.1111/ijd.17401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.17401</ArticleId><ArticleId IdType="pubmed">39095953</ArticleId></ArticleIdList></Reference><Reference><Citation>Seretis K., Bounas N., Gaitanis G., Bassukas I. A Meta-Analysis on the Impact of the COVID-19 Pandemic on Cutaneous Melanoma Diagnosis in Europe. Cancers. 2022;14:6085. doi: 10.3390/cancers14246085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14246085</ArticleId><ArticleId IdType="pmc">PMC9776971</ArticleId><ArticleId IdType="pubmed">36551570</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>